India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

Scrap Uncle Pre Series A Round – IJ represents one of the participating investors

In pre-seed round of Meine Electric, IJ represented investors

IJ advised investor on its pre-seed investment in MiniPix.

Publications

Obtaining a Payment Services Provider (PSP) Licence in GIFT IFSC: Regulatory Framework under IFSCA

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Reframing Liquidation Under IBC: Transitioning From Sale as a Going Concern to Asset-Based Realisation

Newsletters

IFSCA (FM) Amendment Regulations 2026 notified 27 Jan 2026

IFSCA (Anti-Money Laundering, Counter-Terrorist Financing Guidelines: Key Amendments and Their Implications

INDIA’S VDA REGULATORY UPDATE: ENHANCED FIU-IND PROTOCOLS, BUDGET 2026 DISCOURSE, AND THE ‘RISK-FIRST’ COMPLIANCE MODEL